$112 Million is the total value of Concorde Asset Management, LLC's 225 reported holdings in Q4 2022. The portfolio turnover from Q3 2022 to Q4 2022 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| FTS | FORTIS INC | $1,161,160 | +5.4% | 29,000 | 0.0% | 1.03% | -16.2% | |
| PTIX | PROTAGENIC THERAPEUTICS INC | $6,687 | -33.1% | 16,718 | 0.0% | 0.01% | -45.5% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-02-02
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ISHARES TR | 36 | Q3 2023 | 11.9% |
| ISHARES TR | 36 | Q3 2023 | 3.4% |
| SPDR S&P 500 ETF TR | 36 | Q3 2023 | 10.7% |
| APPLE INC | 36 | Q3 2023 | 2.3% |
| FIRST TR VALUE LINE DIVID IN | 36 | Q3 2023 | 5.5% |
| JOHNSON & JOHNSON | 36 | Q3 2023 | 1.9% |
| ISHARES TR | 34 | Q3 2023 | 2.8% |
| ALTRIA GROUP INC | 34 | Q3 2023 | 3.5% |
| JPMORGAN CHASE & CO | 34 | Q3 2023 | 1.1% |
| SPDR GOLD TRUST | 34 | Q3 2023 | 1.5% |
View Concorde Asset Management, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-15 |
| 13F-HR | 2023-11-13 |
| 13F-HR | 2023-07-25 |
| 13F-HR | 2023-05-09 |
| 13F-HR | 2023-02-02 |
| 13F-HR | 2022-10-31 |
| 13F-HR | 2022-08-05 |
| 13F-HR | 2022-04-22 |
| 13F-HR | 2022-02-02 |
| 13F-HR | 2021-10-21 |
View Concorde Asset Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.